Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accessible, ALK, alteration, analyzed, attack, barring, blinded, breakdown, carboplatin, caution, central, centrally, CI, cisplatin, CN, compel, CONTERNO, crime, cyber, delivery, deployment, destruction, disagree, displayed, disseminating, dissemination, drastically, engineering, ensuing, espionage, evacuate, extremely, fourteen, Georgia, hostile, image, Inline, internationally, intrusion, invasion, Jemperli, lab, lapsed, Likewise, MA, MAA, Malaysian, malware, media, mg, military, modestly, notification, olafertinib, ordinary, OS, outsourced, owed, pemetrexed, platinum, prepaid, ransomware, RECIST, recourse, region, regional, reliability, relocate, remediation, Road, route, Sawyer, skilled, Sophisticated, sophistication, suspected, terrorist, topline, Ukraine, verification, version, Waltham, weigh
Removed:
add, energy, Floor, Gansevoort, meant, moving, OTCQX, principally, remove
Filing tables
Filing exhibits
Related press release
CKPT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Checkpoint Therapeutics, Inc.
Waltham, MA
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-251005) and Form S-8 (No. 333-216856, No. 333-221488 and No. 333-251000) of Checkpoint Therapeutics, Inc. of our report dated March 28, 2022, relating to the financial statements which appears in this Annual Report on Form 10-K.
/s/ BDO USA, LLP |
| |
| | |
New York, NY | | |
March 28, 2022 | | |